James H Tonsgard MD

Neurology•Chicago, IL

Associate Professor of Pediatrics and Neurology, University of Chicago Medicine

Join to View Full Profile

5841 S Maryland AveChicago, IL 60637
Phone+1 888-824-0200
Fax+1 773-702-4786

Education & Training

University of ChicagoResidency, Neurology, 1977 - 1981
Yale-New Haven Medical CenterResidency, Pediatrics, 1975 - 1977
Yale School of MedicineClass of 1975

Certifications & Licensure

IL State Medical License 1977 - 2026
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2012-2014
Chicago Magazine: Top Doctors Castle Connolly, 2012, 2014

Clinical Trials

A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1 Start of enrollment: 2009 Jul 01
Completed
Phase 2
Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas Start of enrollment: 2010 Jul 10
Completed
Phase 2
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas Start of enrollment: 2013 May 15
Completed
Phase 2
MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1 Start of enrollment: 2014 Jun 01
Completed
Phase 2
Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults Start of enrollment: 2014 Jun 01
Completed
Phase 2
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs) Start of enrollment: 2015 Nov 13
RECRUITING
MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas Start of enrollment: 2019 Sep 29
ACTIVE_NOT_RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

10 citations
Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.
Scott R Plotkin, Jeffrey Allen, Girish Dhall, Jian L Campian, D Wade Clapp
Neuro-Oncology. 2023-08-03
15 citations
Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.
Pamela L. Wolters, Ana-Maria Vranceanu, Heather L. Thompson, Staci Martin, Vanessa L. Merker
Neurology. 2021-07-06
29 citations
Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1.
Jonathan M. Payne, Kristina M Haebich, Rachel MacKenzie, Karin S. Walsh, Stephen Hearps
Journal of Attention Disorders. 2021-06-01

Grant Support

The Role Of Dicarboxylic Acids In Reye'S SyndromeNational Institute Of Neurological Disorders And Stroke1986–1988